data exclusivity
- Guideline or reference source
- EMA Glossary of terms
- Definition
- The period of eight years from the initial authorisation of a medicine during which the marketing-authorisation holder benefits from the exclusive rights to the results of preclinical tests and clinical trials on the medicine. After this period, the marketing-authorisation holder is obliged to release this information to companies wishing to develop generic versions of the medicine
Send comments to info@celegence.com Please read disclaimer before using Qsauri.